New Client: Gemelli Biotech

Welcome to the TryMus Family, Gemelli Biotech!

Our newest client, Gemelli Biotech, is a leader in biological discoveries related to the gut microbiome. They provide non-invasive precision diagnostics which enable clinicians to optimally treat gastrointestinal (GI) diseases including: small intestinal bacterial overgrowth (SIBO), intestinal methanogenic overgrowth (IMO), excess hydrogen sulfide, and post-infectious IBS.

TryMus is managing Gemelli Biotech’s product, trio-smart, on Facebook and Instagram. Trio-smart is an at-home breath test that measures the levels of hydrogen, methane, and hydrogen sulfide in a patient’s breath to determine if they are elevated abnormally. As the only test available that measures all three of these gases, trio-smart aids in the most precise identification of GI diseases.

The first step to feeling better. The answer could be in your breath.

With a goal to educate customers and provide reliable, accessible diagnostics, TryMus has developed a social media strategy that is friendly and informative, while asserting scientific authority—both visually and narratively. Our strategy aims to raise awareness of GI conditions, promote ownership of your own health, and to encourage breath testing.

We are thrilled to be working with you, Gemelli Biotech!